SQUAMOUS CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Groundbreaking cancer drug enters first human trials
Disease control Recruiting nowThis is the first human study testing a new cancer drug called TT125-802 in people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to check if the drug is safe and well-tolerated, while also looking for early signs that it might he…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Targeted drug trial aims to slow aggressive lung cancer
Disease control Recruiting nowThis study is testing an experimental drug called ZEN003694 for people with advanced squamous cell lung cancer that has a specific genetic change (NSD3 amplification). The drug works by blocking certain proteins that help the cancer grow. Researchers want to see if this treatment…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New immune cell therapy tested for Tough-to-Treat lung cancer
Disease control Recruiting nowThis is an early-stage trial testing the safety of a new type of personalized immune cell therapy called C-CAR031. It is for adults with an advanced form of squamous cell lung cancer that has a specific marker (GPC3+) and has stopped responding to up to three prior treatments. Th…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC